{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:01:31Z","timestamp":1792324891483,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["FAF-FA\/2016\/818"],"award-info":[{"award-number":["FAF-FA\/2016\/818"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jtho.2021.05.015","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T02:11:49Z","timestamp":1622427109000},"page":"1461-1478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Janah","family":"Vandenhoeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-7461","authenticated-orcid":false,"given":"Kevin","family":"Lamote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2021.05.015_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0039-1693406","article-title":"Malignant mesothelioma: has anything changed?","volume":"40","author":"Kim","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"suppl 5","key":"10.1016\/j.jtho.2021.05.015_bib2","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib3","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","article-title":"Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma","volume":"29","author":"Christensen","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2021.05.015_bib5","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.3390\/ijerph17186900","article-title":"Burden of mesothelioma deaths by national income category: current status and future implications","volume":"17","author":"Chimed-Ochir","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"suppl 1","key":"10.1016\/j.jtho.2021.05.015_bib6","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib7","first-page":"319","article-title":"Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health","volume":"110","author":"Neumann","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jtho.2021.05.015_bib8","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2021.05.015_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00001622-200303000-00002","article-title":"Predictive and prognostic factors in malignant pleural mesothelioma","volume":"15","author":"Baas","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200806-955ED","article-title":"Screening for mesothelioma: more harm than good?","volume":"178","author":"van Meerbeeck","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCP.0b013e32812144bb","article-title":"Biomarkers for mesothelioma","volume":"13","author":"Scherpereel","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.4567","article-title":"Epigenetic down-regulation of integrin \u03b17 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma","volume":"237","author":"Laszlo","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.jtho.2021.05.015_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.04.011","article-title":"Cytogenetic and molecular genetic changes in malignant mesothelioma","volume":"170","author":"Musti","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jtho.2021.05.015_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2021.05.015_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.22341","article-title":"Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers","volume":"120","author":"Tomii","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","article-title":"Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung","volume":"47","author":"Tsou","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.lungcan.2007.06.015","article-title":"DNA methylation profile of 28 potential marker loci in malignant mesothelioma","volume":"58","author":"Tsou","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib18","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/cancers11111810","article-title":"The gasdermin e gene potential as a pan-cancer biomarker, while discriminating between different tumor types","volume":"11","author":"Ibrahim","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2021.05.015_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtho.2021.05.015_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based. Ment Health"},{"key":"10.1016\/j.jtho.2021.05.015_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jtho.2021.05.015_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib23","first-page":"6223","article-title":"Methylation-associated silencing of microRNA-126 and its host gene EGFL7 in malignant pleural mesothelioma","volume":"35","author":"Andersen","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2006.02.084","article-title":"Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma","volume":"342","author":"Batra","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtho.2021.05.015_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40248-018-0137-4","article-title":"5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin","volume":"13","author":"Bosio","year":"2018","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cyt.12782","article-title":"MGMT promoter methylation is a rare epigenetic change in malignant effusions","volume":"31","author":"Brunetti","year":"2020","journal-title":"Cytopathology"},{"key":"10.1016\/j.jtho.2021.05.015_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molonc.2012.11.004","article-title":"HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression","volume":"7","author":"Cartron","year":"2013","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e3182a0840a","article-title":"ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma","volume":"8","author":"Cheng","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib29","doi-asserted-by":"crossref","first-page":"2536187","DOI":"10.1155\/2017\/2536187","article-title":"SFRP tumour suppressor genes are potential plasma-based epigenetic biomarkers for malignant pleural mesothelioma","volume":"2017","author":"Cheng","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.jtho.2021.05.015_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2007.08.035","article-title":"Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient\u2019s follow-up","volume":"59","author":"Destro","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jmoldx.2020.04.205","article-title":"Treatment response monitoring in patients with advanced malignancies using cell-free SHOX2 and SEPT9 DNA methylation in blood: an observational prospective study","volume":"22","author":"de Vos","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jtho.2021.05.015_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","article-title":"Promoter methylation of RASSF1A, RAR beta and DAPK predict poor prognosis of patients with malignant mesothelioma","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1349-7006.2011.02180.x","article-title":"Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma","volume":"103","author":"Fujii","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtho.2021.05.015_bib35","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib36","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s13277-012-0462-8","article-title":"Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma","volume":"33","author":"Hama","year":"2012","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jtho.2021.05.015_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00432-012-1158-6","article-title":"DNA methylation status of REIC\/Dkk-3 gene in human malignancies","volume":"138","author":"Hayashi","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/0008-5472.743.65.3","article-title":"Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells","volume":"65","author":"He","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib39","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1073\/pnas.2232790100","article-title":"SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer","volume":"100","author":"He","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2021.05.015_bib40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/carcin\/23.7.1127","article-title":"Alterations of the p16(INK4) locus in human malignant mesothelial tumors","volume":"23","author":"Hirao","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2021.05.015_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the microRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib42","first-page":"1265","article-title":"The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas","volume":"20","author":"Kimura","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtho.2021.05.015_bib43","first-page":"1087","article-title":"Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas","volume":"12","author":"Kobatake","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtho.2021.05.015_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2008.02.013","article-title":"Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma","volume":"62","author":"Kobayashi","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib45","first-page":"423","article-title":"Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma","volume":"24","author":"Kohno","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtho.2021.05.015_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbrc.2009.12.095","article-title":"An epigenetic mechanism for capecitabine resistance in mesothelioma","volume":"391","author":"Kosuri","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtho.2021.05.015_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JTO.0b013e318168da0a","article-title":"Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16(INK4a) - results of cancer and leukemia group B 159904","volume":"3","author":"Kratzke","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2021.05.015_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.lungcan.2010.05.008","article-title":"Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP","volume":"71","author":"Kristensen","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib49","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of MicroRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib50","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1038\/sj.onc.1207881","article-title":"Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2021.05.015_bib51","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2016.06.097","article-title":"Inhibition of the polyamine synthesis pathway is synthetically lethal with loss of argininosuccinate synthase 1","volume":"16","author":"Locke","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtho.2021.05.015_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41416-019-0379-8","article-title":"MST1\/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial","volume":"120","author":"Maille","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib53","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1158\/0008-5472.CAN-06-1687","article-title":"Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors","volume":"66","author":"Marsit","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lungcan.2013.09.017","article-title":"The degree of microRNA-34b\/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma","volume":"82","author":"Muraoka","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.onc.1203322","article-title":"Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma","volume":"19","author":"Murthy","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2021.05.015_bib56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4161\/epi.6.8.16074","article-title":"The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma","volume":"6","author":"Nelson","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.jtho.2021.05.015_bib57","doi-asserted-by":"crossref","first-page":"19478","DOI":"10.1074\/jbc.M110.217331","article-title":"Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism","volume":"286","author":"Nocchi","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtho.2021.05.015_bib58","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1158\/1078-0432.CCR-06-1101","article-title":"In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion","volume":"12","author":"Szlosarek","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib59","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/dc.20692","article-title":"Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study","volume":"35","author":"Pu","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jtho.2021.05.015_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.lungcan.2015.09.021","article-title":"Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma","volume":"90","author":"Santarelli","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib61","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ijc.20622","article-title":"Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies","volume":"113","author":"Shigematsu","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ijc.20041","article-title":"Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types","volume":"109","author":"Shivapurkar","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib63","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.humpath.2010.03.002","article-title":"Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter","volume":"41","author":"Tan","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2021.05.015_bib64","first-page":"179","article-title":"Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma","volume":"65","author":"Teramen","year":"2011","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jtho.2021.05.015_bib65","first-page":"5727","article-title":"Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma","volume":"61","author":"Toyooka","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.12688\/f1000research.13944.1","article-title":"Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types","volume":"7","author":"Vrba","year":"2018","journal-title":"F1000 Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0169-5002(02)00178-2","article-title":"Inactivation of p16INK4a expression in malignant mesothelioma by methylation","volume":"38","author":"Wong","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2021.05.015_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtho.2021.05.015_bib69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/carcin\/20.5.773","article-title":"Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen","volume":"20","author":"Xu","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2021.05.015_bib70","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/0008-5472.CAN-09-1073","article-title":"Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2021.05.015_bib71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1458","article-title":"Cadherins, catenins and APC in pleural malignant mesothelioma","volume":"201","author":"Abutaily","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.jtho.2021.05.015_bib72","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1038\/cddis.2014.219","article-title":"Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence","volume":"5","author":"Ramachandran","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtho.2021.05.015_bib73","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib74","first-page":"1","article-title":"MiR-34a and miR-34b\/c have distinct effects on the suppression of lung adenocarcinomas","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jtho.2021.05.015_bib75","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.18632\/oncotarget.23870","article-title":"Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2021.05.015_bib76","first-page":"1114","article-title":"A systematic profile of DNA methylation in human cancer cell lines","volume":"63","author":"Paz","year":"2003","journal-title":"Cancer Res"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086421021869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086421021869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:04Z","timestamp":1761562024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086421021869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1556086421021869"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2021.05.015","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2021.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}